Press Releases Year None202620252024202320222021 July 2, 2026 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 1, 2026 NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026 June 3, 2026 NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions May 28, 2026 NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June May 11, 2026 NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May May 7, 2026 NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results May 1, 2026 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 8, 2026 NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference April 2, 2026 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 23, 2026 NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
July 1, 2026 NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
June 3, 2026 NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
May 7, 2026 NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
April 8, 2026 NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
March 23, 2026 NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
